The present disclosure relates to systems, methods, and products for separating magnetic particles from a fluid.
Activation and expansion of human T cells may include introducing feeder cells (e.g., antigen-presenting cells) or T-cell activating antibodies to T-cell culture. Post-activation and expansion removal of the antibodies or antigen-presenting feeder cells, however, may require laborious purification. Alternatively, more sophisticated magnetic bead systems may introduce into the cell culture an amount of magnetic beads that are covalently coupled to specific antibodies (e.g., anti-CD3, anti-CD28, anti-CD137, etc.), which may provide primary and co-stimulatory signals, optimized for efficient T cell activation and expansion. The magnetic beads may then be removed using a magnetic device. For instance, the magnetic bead-containing culture may be exposed to (e.g., fluidly passed over) a magnetic device that retains the antibody-bound magnetic beads, allowing the activated and expanded T-cells to be purified away from the beads.
By way of illustration,
One problem with existing systems is that some of the magnetic beads may not retained by magnetic field 18 and, therefore, contaminate the product recovered through outlet 16. To remove substantially all of the magnetic beads, the mixture may need to be exposed to magnetic field 18 multiple times. For instance, the mixture may need to be circulated through bag 10 multiple times (e.g., twice, or more than twice) in order to re-expose the magnetic beads to magnetic field 18. Alternatively, or in addition, users may ensure that the magnetic bead-containing culture flows through compartment 12 at a low flow rate to ensure that the magnetic beads are exposed to magnetic field 18 for a sufficient amount of time (e.g., less than 20-30 mL/min). Other solutions include wrapping an outlet tube that extends from outlet 16 around a secondary magnet so that the recovered product is exposed to a second magnetic field that retains the magnetic beads within the outlet tubing. Recirculation, reduced flow rate, and secondary magnets can increase the time and cost required for removing the magnetic beads from the mixture. Time-consuming measures add expensive delay and require operator monitoring in commercial applications. Costly additional components (e.g., magnets) also increase the overall cost of sample production and purification.
Accordingly, there are a number of disadvantages with conventional magnetic bead-removal systems that can be addressed.
Embodiments of the present disclosure solve one or more of the foregoing or other problems in the art with systems, methods, and products for separating magnetic particles from a fluid. Methods can include introducing a fluid mixture into an internal compartment of a container. The container can be flexible. For instance, the container can be or comprise a flexible bag. The fluid mixture can be introduced into the internal compartment through an inlet of the container. The inlet can be in fluid communication with the internal compartment. The fluid mixture can include a liquid media. The fluid mixture can include a biological component. The fluid mixture can include magnetic particles.
Some embodiments include allowing at least a portion of the mixture to travel around a partition. The partition can be formed within the internal compartment. Some embodiments include allowing at least a portion of the mixture to exit the internal compartment through an outlet. The outlet can be disposed on the opposite side of the partition from the inlet. The outlet can be in fluid communication with the internal compartment.
Some embodiments include applying a magnetic field. The magnetic field can be applied to the mixture. The magnetic field can be applied in the internal compartment. The magnetic particles are, can be, or become retained within the container or internal compartment thereof by or by means of the magnetic field. In some embodiments, the magnetic particles are, can be, or become retained within the container or internal compartment thereof by or by means of the magnetic field as the media and biological component flow from the inlet, around the partition and to the outlet.
In some embodiments, the biological component comprises cells. In some embodiments, the cells comprise activated and/or expanded human T-cells. In some embodiments, the biological component comprises one or more nucleic acids, proteins, such as antibodies, fats, fatty acids, or combination(s), aggregate(s), or precipitate(s) thereof.
In some embodiments, the magnetic particles comprise beads. In some embodiments, the magnetic particles comprise inert, superparamagnetic beads. In some embodiments, the beads have one or more anti-CD3 antibodies coupled thereto. In some embodiments, the beads have one or more anti-CD28 antibodies coupled thereto. In some embodiments, the beads have one or more anti-CD3 and one or more anti-CD28 antibodies coupled thereto. The beads can optionally have a substantially uniform diameter. The diameter can be about 4.5 μm.
In some embodiments, the fluid mixture comprises a suspension cell culture. The suspension cell culture can comprise cells. The cells can be growing in a liquid media. In some embodiments, the suspension cell culture is disposed in a bioreactor. In some embodiments, the introduced fluid mixture optionally flows from the bioreactor into the internal compartment of the container. In some embodiments, the fluid mixture is introduced into the internal compartment at a flow rate greater than or equal to about 20-30 mL/min. In some embodiments, the portion of the fluid mixture that exits the internal compartment through the outlet comprises less than 5000, preferably less than 1000, more preferably less than 100, most preferably less than 20 magnetic particles per milliliter of liquid media.
Some embodiments may include any of the features, options, and/or possibilities set out elsewhere in the present disclosure, including in other aspects or embodiments of the present disclosure.
Some embodiments include disposing the container on or in a magnetic field-generating device. Some embodiments include closing a lid of the magnetic field-generating device. The lid can be closed against the container such that at least a portion of the container becomes flattened into a substantially two-dimensional configuration.
In some embodiments, the flexible container comprises an upper container wall. In some embodiments, the flexible container comprises a lower container wall. The upper and lower container walls can be joined at an encircling perimeter. In some embodiments, the partition can comprise a joinder of the upper container wall and lower container wall. In some embodiments, the partition can extend from the perimeter into the internal compartment.
In some embodiments, the inlet extends through the joined perimeter. In some embodiments, the outlet extends through the joined perimeter. In some embodiments, the partition comprises at least one weld between the upper container wall and lower container wall. Some embodiments include forming the partition by reversibly pressing together the upper container wall and the lower container wall. Some embodiments include forming the partition by reversibly pressing together the upper container wall and the lower container wall such that the media and biological component flow or must flow around the partition. Some embodiments include forming the partition by reversibly pressing together the upper container wall and the lower container wall such that the media and biological component flow or must flow around the partition to flow through the outlet.
In some embodiments, the partition extends from a first location. The first location can be disposed proximal to the inlet. The first location can be disposed proximal to the outlet. In some embodiments, the first location is disposed between the inlet and the outlet. In some embodiments, the first location is disposed between and proximal to the inlet and the outlet. In some embodiments, the partition extends to a second location. The second location can be disposed within the internal compartment. The second location can be disposed distal to the inlet. The second location can be disposed distal to the outlet. In some embodiments, the partition extends from a first location to a second location.
In some embodiments, the inlet comprises a first opening. The first opening can have a first diameter. In some embodiments, the outlet comprising a second opening. The second opening can have a second diameter. In some embodiments, the first opening is in fluid communication with the internal compartment. In some embodiments, the second opening is in fluid communication with the internal compartment.
In some embodiments, the partition extends beyond at least the first opening. In some embodiments, the partition extends beyond at least the first opening a first distance. In some embodiments, the partition extends beyond at least the first opening a first distance into the internal compartment. In some embodiments, the first distance can be at least half the first diameter. In some embodiments, the first distance can be less than 10 times, 50 times, 100 times, 150 times, 200 times, 250 times, 300 times or 350 times the first diameter. In some embodiments, the partition extends beyond the second opening.
In some embodiments, the partition extends beyond the second opening. In some embodiments, the partition extends beyond the second opening the first distance. In some embodiments, the partition extends beyond the second opening a second distance. In some embodiments, the partition extends beyond the second opening the first distance into the internal compartment. In some embodiments, the partition extends beyond the second opening a second distance into the internal compartment. In some embodiments, the second distance is less than the first distance. In some embodiments, the second distance is greater than the first distance. In some embodiments, the first distance is equal to the first distance.
In some embodiments, the first opening is disposed on, at, or in a first side of the container. In some embodiments, second opening is disposed on, at, or in the first side of the container. In some embodiments, second opening is disposed on, at, or in a second side of the container. The second side of the container can be disposed opposite the first side of the container. In some embodiments, the first and second openings are disposed on, at, or in opposite first and second sides of the partition.
In some embodiments, the first opening comprises a tubular member. In some embodiments, the second opening comprises a tubular member. In some embodiments, the tubular member(s) can extend through the joined perimeter. In some embodiments, the tubular member(s) can extend through the flexible container. In some embodiments, the tubular member(s) can extend through the upper container wall. In some embodiments, the tubular member(s) can extend through the lower container wall.
In some embodiments, at least a portion of the container is disposed on or in a magnetic field-generating device. The device can produce a magnetic field within at least a portion of the compartment. The device can be producing a magnetic field within at least a portion of the compartment.
Some embodiments include introducing a first fluid mixture into a flexible container. Some embodiments include introducing a first fluid mixture into an internal compartment of a flexible container. Some embodiments include introducing a first fluid mixture into an internal compartment of a flexible container through a first opening.
In some embodiments, the first mixture comprises a liquid media. In some embodiments, the first mixture comprises a first amount of magnetic particles. The first amount of magnetic particles can be disposed in the liquid media. The biological component can be disposed in the liquid media. The biological component can be disposed in the liquid media at a first concentration.
Some embodiments can include removing a second fluid mixture from the compartment. The second fluid mixture can be removed from the compartment through a second opening. The second opening can be disposed in the first side of the container. The second opening can be disposed adjacent to the first opening. The second mixture can comprise the liquid media. The second mixture can comprise the liquid media the biological component. The biological component can be disposed in the liquid media. The biological component can be disposed in the liquid media at a second concentration. The second concentration can be greater than the first concentration. The second concentration can be greater than 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% of the first concentration. The second fluid can have or comprise less than 5000 magnetic particles per milliliter of liquid media, preferably less than 1000 magnetic particles per milliliter of liquid media, more preferably less than 100 magnetic particles per milliliter of liquid media, even more preferably less than 20 magnetic particles per milliliter of liquid media.
The magnetic field can retain at least a portion of the first amount of magnetic particles in the compartment. The compartment can have a partition formed therein. The partition can be or comprise a joinder of the upper container wall and lower container wall. The partition can have a sealed first end extending from the first side of the container. The partition can have a sealed first end extending from the first side of the container adjacent to the first opening. The partition can have a sealed first end extending from the first side of the container between the first opening and the second opening. The partition can have a second end opposite the first end. The second end can be disposed at a second location within the compartment. In some embodiments, the liquid media and the biological component must pass from the first opening, around the partition, and to the second opening in order to be removed from the compartment.
Some embodiments may include any of the features, options, and/or possibilities set out elsewhere in the present disclosure, including in other aspects or embodiments of the present disclosure.
Some embodiments can include a magnetic particle separation system, comprising (i) a magnetic field generating device, the magnetic field generating device comprising a (a) receiving area having an upper surface, and (b) a magnetic field generating element disposed beneath the upper surface of the receiving area, the magnetic field generating element configured to produce a magnetic field above the surface, and (ii) a container assembly disposed on the surface, the container assembly comprising (a) a flexible container comprising an outer wall having an interior surface that at least partially bounds an internal compartment, (b) a fluid inlet extending through the outer wall, the inlet being in fluid communication with the compartment, (c) a fluid outlet extending through the outer wall, the outlet being adjacent to the inlet, the outlet being in fluid communication with the compartment, and (d) a first partition formed in the internal compartment, the partition comprising a joinder of opposing sides of the interior surface between the fluid inlet and the fluid outlet.
In some embodiments, the magnetic field generating device further comprises a lid. The lid can be disposed over the upper surface of the receiving area. At least a portion of the flexible container can be disposed between the upper surface and the lid. At least a portion of the flexible container can be disposed between the upper surface and the lid such that such that at least a portion of the flexible container becomes flattened into a substantially two-dimensional configuration. In some embodiments, the outer wall of the flexible container comprises an upper container wall and a lower container wall joined at an encircling perimeter. The outer wall can be formed of a flexible, polymeric, water impermeable sheet material.
In some embodiments, the fluid inlet comprises a first opening disposed in the outer wall or extending through the joined perimeter on a first side of the container, the first opening being in fluid communication with the internal compartment. In some embodiments, the fluid outlet comprises a second opening disposed in the outer wall or extending through the joined perimeter on the first side of the container adjacent to the first opening, the second opening being in fluid communication with the internal compartment. In some embodiments, the first partition extends from the perimeter into the internal compartment. The first partition can comprise a joinder of the upper container wall and the lower container wall, the first partition having a sealed first end extending from the first side of the container between the first opening and the second opening and a second end opposite the first end disposed at a second location within the internal compartment such that a fluid passing from the fluid inlet to the fluid outlet must flow around the second end of the first partition as direct, linear access between the fluid inlet and the fluid outlet is restricted by the first partition. In some embodiments, the first opening has a first diameter and the second opening has a second diameter, the partition extending beyond at least the first opening a first distance into the internal compartment, the first distance being at least half the first diameter and less than 10 times, 50 times, 100 times, 150 times, 200 times, 250 times, 300 times or 350 times the first diameter.
In some embodiments, the magnetic field generating device further comprises a fluid mixture disposed in the internal compartment, the fluid mixture comprising a liquid media, a biological component, and magnetic particles. In some embodiments, the magnetic field generating device further comprises a magnetic field produced by the magnetic field generating element above the upper surface and within the internal compartment, the magnetic particles being secured to the interior surface by the magnetic field. In some embodiments, the biological component comprises activated human T-cells. In some embodiments, the magnetic particles comprise beads. In some embodiments, the magnetic particles comprise inert, superparamagnetic beads. In some embodiments, the beads have one or more anti-CD3 antibodies coupled thereto. In some embodiments, the beads have one or more anti-CD28 antibodies coupled thereto. In some embodiments, the beads have one or more anti-CD3 and one or more anti-CD28 antibodies coupled thereto. The beads can optionally have a substantially uniform diameter. The diameter can be about 4.5 μm. The fluid mixture can comprise a suspension cell culture of the human T-cells in the liquid media. The fluid mixture can comprise a suspension cell culture of the human T-cells growing in the liquid media. In some embodiments, the system further comprises a bioreactor fluidly coupled to the internal compartment of the container.
Some embodiments may include any of the features, options, and/or possibilities set out elsewhere in the present disclosure, including in other aspects or embodiments of the present disclosure.
Some embodiments include a container assembly, comprising (i) a flexible container comprising an outer wall having an interior surface that at least partially bounds an internal compartment, the outer wall comprising an upper container wall and a lower container wall joined at an encircling perimeter, the outer wall being formed of a flexible, polymeric, water impermeable sheet material, (ii) a fluid inlet comprising a first opening disposed in the outer wall or extending through the joined perimeter on a first side of the container, the first opening being in fluid communication with the internal compartment, the first opening having a first diameter, (iii) a fluid outlet comprising a second opening disposed in the outer wall or extending through the joined perimeter on the first side of the container adjacent to the first opening, the second opening being in fluid communication with the internal compartment, the second opening having a second diameter, and (iv) a first partition formed in the internal compartment and extending from the perimeter into the internal compartment a first distance beyond at least the first opening, the first distance being at least half the first diameter and less than 350 times the first diameter, the first partition comprising a joinder of the upper container wall and the lower container wall, the first partition having a sealed first end extending from the first side of the container between the first opening and the second opening and a second end opposite the first end disposed within the internal compartment such that a fluid passing from the fluid inlet to the fluid outlet must flow around the first partition, and such that direct, linear access between the fluid inlet and the fluid outlet is restricted by the first partition.
Some embodiments may include any of the features, options, and/or possibilities set out elsewhere in the present disclosure, including in other aspects or embodiments of the present disclosure. It is also noted that each of the foregoing, following, and/or other features described herein represent a distinct embodiment of the present disclosure. Moreover, combinations of any two or more of such features represent distinct embodiments of the present disclosure. Such features or embodiments can also be combined in any suitable combination and/or order without departing from the scope of this disclosure. Thus, each of the features described herein can be combinable with any one or more other features described herein in any suitable combination and/or order. Accordingly, the present disclosure is not limited to the specific combinations of exemplary embodiments described in detail herein.
Additional features and advantages of exemplary embodiments of the present disclosure will be set forth in the description which follows, and in part will be obvious from the description, or may be learned by the practice of such exemplary embodiments. The features and advantages of such embodiments may be realized and obtained by means of the instruments and combinations particularly pointed out in the appended claims. These and other features will become more fully apparent from the following description and appended claims, or may be learned by the practice of such exemplary embodiments as set forth hereinafter.
In order to describe the manner in which certain advantages and features of the present disclosure can be obtained, a description of the disclosure will be rendered by reference to specific embodiments thereof which are illustrated in the appended drawings. Understanding that these drawings depict only typical embodiments of the disclosure and are not therefore to be considered to be limiting of its scope, the disclosure will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:
Before describing various embodiments of the present disclosure in detail, it is to be understood that this disclosure is not limited to the specific parameters and description of the particularly exemplified systems, methods, and/or products that may vary from one embodiment to the next. Thus, while certain embodiments of the present disclosure will be described in detail, with reference to specific features (e.g., configurations, parameters, properties, steps, components, ingredients, members, elements, parts, and/or portions, etc.), the descriptions are illustrative and are not to be construed as limiting the scope of the present disclosure and/or the claimed invention. In addition, the terminology used herein is for the purpose of describing the embodiments, and is not necessarily intended to limit the scope of the present disclosure and/or the claimed invention.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the present disclosure pertains.
Various aspects of the present disclosure, including systems, processes, and/or products may be illustrated with reference to one or more embodiments or implementations, which are exemplary in nature. As used herein, the terms “embodiment” and implementation” mean “serving as an example, instance, or illustration,” and should not necessarily be construed as preferred or advantageous over other aspects disclosed herein. In addition, reference to an “implementation” of the present disclosure or invention includes a specific reference to one or more embodiments thereof, and vice versa, and is intended to provide illustrative examples without limiting the scope of the invention, which is indicated by the appended claims rather than by the following description.
As used throughout this application the words “can” and “may” are used in a permissive sense (i.e., meaning having the potential to), rather than the mandatory sense (i.e., meaning must). Additionally, the terms “including,” “having,” “involving,” “containing,” “characterized by,” as well as variants thereof (e.g., “includes,” “has,” and “involves,” “contains,” etc.), and similar terms as used herein, including the claims, shall be inclusive and/or open-ended, shall have the same meaning as the word “comprising” and variants thereof (e.g., “comprise” and “comprises”), and do not exclude additional, un-recited elements or method steps, illustratively.
It will be noted that, as used in this specification and the appended claims, the singular forms “a,” “an” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to a “partition” includes one, two, or more partitions.
As used herein, directional terms, such as “top,” “bottom,” “left,” “right,” “up,” “down,” “upper,” “lower,” “proximal,” “distal” and the like are used herein solely to indicate relative directions and are not otherwise intended to limit the scope of the disclosure and/or claimed invention.
Various aspects of the present disclosure can be illustrated by describing components that are bound, coupled, attached, connected, and/or joined together. As used herein, the terms “bound,” “coupled”, “attached”, “connected,” and/or “joined” are used to indicate either a direct association between two components or, where appropriate, an indirect association with one another through intervening or intermediate components. In contrast, when a component is referred to as being “directly bound,” “directly coupled”, “directly attached”, “directly connected,” and/or “directly joined” to another component, no intervening elements are present or contemplated. Furthermore, binding, coupling, attaching, connecting, and/or joining can comprise mechanical and/or chemical association.
To facilitate understanding, like reference numerals (i.e., like numbering of components and/or elements) have been used, where possible, to designate like elements common to the figures. Specifically, in the exemplary embodiments illustrated in the figures, like structures, or structures with like functions, will be provided with similar reference designations, where possible. Specific language will be used herein to describe the exemplary embodiments. Nevertheless it will be understood that no limitation of the scope of the disclosure is thereby intended. Rather, it is to be understood that the language used to describe the exemplary embodiments is illustrative only and is not to be construed as limiting the scope of the disclosure (unless such language is expressly described herein as essential). Furthermore, multiple instances of an element and or sub-elements of a parent element may each include separate letters appended to the element number. Furthermore, an element label with an appended letter can be used to designate an alternative design, structure, function, implementation, and/or embodiment of an element or feature without an appended letter. Likewise, an element label with an appended letter can be used to indicate a sub-element of a parent element. However, element labels including an appended letter are not meant to be limited to the specific and/or particular embodiment(s) in which they are illustrated. In other words, reference to a specific feature in relation to one embodiment should not be construed as being limited to applications only within said embodiment.
It will also be appreciated that where multiple possibilities of values or a range a values (e.g., less than, greater than, at least, or up to a certain value, or between two recited values) is disclosed or recited, any specific value or range of values falling within the disclosed range of values is likewise disclosed and contemplated herein.
The headings used herein are for organizational purposes only and are not meant to be used to limit the scope of the description or the claims.
The present invention relates to systems, methods, and products for separating magnetic particles from a fluid. Methods can include introducing a fluid mixture into an internal compartment of a container through an inlet. The fluid mixture can include a liquid media, a biological component, and magnetic particles. Methods also include allowing at least a portion of the mixture to travel around a partition formed within the internal compartment. The mixture can then exit the internal compartment through an outlet (e.g., on the opposite side of the partition from the inlet). Methods also include applying a magnetic field to the mixture (e.g., in the internal compartment) so that the magnetic particles are retained within the container or internal compartment thereof by the magnetic field.
As used herein, the term “systems” also contemplates devices, apparatus, compositions, assemblies, kits, and so forth. Similarly, the term “products” also contemplates devices, apparatus, compositions, assemblies, kits, and so forth. Moreover, the term “methods” also contemplates processes, procedures, steps, and so forth.
As used herein, the term “fluid mixture” can comprise any suitable composition and/or combination of the specific components thereof. For instance, the mixture can comprise a solution, suspension, colloid, emulsion, or other mixture (e.g., in which the biological component and magnetic particles are disposed in the fluid (e.g., liquid) media.
As used herein, the term “biological component” includes one or more cells (e.g., T-cells, whether human or non-human, activated or inactivated, etc.), molecules (e.g., elements), compounds (e.g., nucleic acids, proteins, such as antibodies, fats, fatty acids, etc.), or combination(s), aggregate(s), or precipitate(s) thereof.
As used herein, the term “magnetic particle,” and the like, refers to a component that responds (magnetically) to and/or is (magnetically) susceptible to a magnetic field. The component can comprise or be formed of material that is attracted into and/or repelled out of a magnetic field. In some embodiments, the component can comprise a paramagnetic or superparamagnetic particle (or magnetic bead). The bead can comprise a (substantially spherical) polymer (e.g., polystyrene). The polymeric bead can have a uniform size and a consistent, defined surface (e.g., useful for the adsorption or coupling of one or more bioreactive molecules or cells). In at least some embodiments, the bead can have a diameter greater than 50 nm (e.g., the approximate size of magnetic-activated cell sorting beads). In certain embodiments, the bead can be between 1 nm and 100 mm, between 100 nm and 1 mm, between 500 nm and 100 μm, between 1 μm and 10 μm, between 1 μm and 5 μm, or between 4 μm and 5 μm in diameter. In certain embodiments, the bead can be (covalently) linked to a molecule and/or compound (e.g., an antibody that recognizes a specific protein on the surface of the target cell-type).
As used herein, the term “diameter,” whether in reference to the size of a particle (e.g., a bead) or other component (e.g., an opening), is not limited to the measurement of circular or spherical components. Rather, whether circular, oval or oblong, rectangular, angle or jagged, or a combination thereof, the diameter of the component can refer to a (cross-sectional) measurement between opposing sides and/or the (maximum or minimum) distance between the opposing sides.
Reference will now be made the figures of the present disclosure. It is noted that the figures are not necessarily drawn to scale and that the size, orientation, position, and/or relationship of or between various components can be altered in some embodiments without departing from the scope of this disclosure.
Depicted in
Containers
In the depicted embodiment, container 21 comprises a flexible (e.g., pliable, malleable, bendable, etc.) and/or collapsible, pillow type bag that is formed from two overlapping sheets of polymeric material (i.e., film) that are seamed together around a perimeter 36. In particular, container 21 comprises an upper container wall (or sheet) 32 and a lower container wall (or sheet) 34 disposed in an overlapping relationship, with sheets 32 and 34 joined together at their peripheries to form an (encircling) perimeter 36 to form an outer wall 27 of container 21. Outer wall 27 (or each sheet 32 and 34 thereof) has an exterior surface 40 and an opposing interior surface that bounds an internal compartment 22. Perimeter 36 forms a water impermeable seal at the interface between sheets 32 and 34. For instance, perimeter 36 can comprise a weld between sheets 32 and 34.
Perimeter 36 (or the weld thereof) has an inner perimeter edge 37 facing compartment 22 and an outer perimeter edge 38 extending around the exterior of container 21. Perimeter 36 also comprises a first or lower perimeter edge 50 disposed on a first side (or lower end) 51 of container 21 and an opposing second or upper perimeter edge 52 disposed on a second side (or upper end) 53 of container 21. Container 21 also has opposing side perimeter edges 54 and 56 extending between first perimeter edge 50 and opposing second perimeter edge 52. In the depicted embodiment, container 21 further includes opposing transition perimeter edges 58a and 58b disposed at the transition between first perimeter edge 50 and opposing side perimeter edges 54 and 56, respectively. Accordingly, edges 50, 52, 54, 56, 58a, and 58b combine to form perimeter (edge) 36.
Transition perimeter edges 58a, 58b are angled relative to first perimeter edge 50 and opposing side perimeter edges 54 and 56, respectively. In particular, first perimeter edge 50 and opposing side perimeter edges 54 and 56, respectively, can be disposed and/or oriented substantially perpendicular (i.e., 90 degree angle relative) to one another. Transition perimeter edges 58a, 58b can be disposed and/or oriented at an approximately 45 degree angle relative to first perimeter edge 50 and opposing side perimeter edges 54 and 56, respectively. It will be appreciated, however, that a variety of configurations, including rounded, multi-angular, and so forth, can also be suitable for transition perimeter edges 58a, 58b. Regardless of specific configuration, transition perimeter edges 58a, 58b can occupy, remove, and/or eliminate a portion (e.g., a lower corner portion between first perimeter edge 50 and opposing side perimeter edges 54 and 56, respectively) of compartment 22, thereby reducing the volume or area of internal compartment 22 and/or the lower corner portion. Certain alternative embodiments need not include one or more of transition perimeter edges 58a, 58b.
A plurality of openings 70 transversely extend through perimeter 36. For instance, opposing first opening 70a and second opening 70b are disposed at the corner or interface between first perimeter edge 50 and transition edges 58a, 58b, respectively. Container 21 also has a securing tab 72 disposed at and/or extending from upper perimeter edge 52. A third opening 70c extends through securing tab 72. While openings 70 extend through perimeter 36 of container 21 or outer wall 27 thereof, openings 70 do not communicate with compartment 22. Rather, openings 70 extend through the welded perimeter edge portion of container 21 between inner perimeter edge 37 and outer perimeter edge 38 thereof.
Regardless of specific configuration, shape, size, etc., container 21, 21a of the present disclosure can be comprised of any material suitable for the forming such bags. In at least one embodiment, container 21, 21a can be comprised of water impermeable material such as a low-density polyethylene or other polymeric film having a thickness in a range between about 0.1 mm to about 5 mm with about 0.2 mm to about 2 mm being more common. The polymeric film can have a thickness that is at least or less than 0.02 mm, 0.05 mm, 0.1 mm, 0.2 mm, 0.5 mm, 1 mm, 2 mm, 3 mm or in a range between any two of the foregoing. Other thicknesses can also be used. The film is typically sufficiently flexible that it can be rolled into a tube without plastic deformation and/or can be folded over an angle of at least 90°, 180°, 270°, or 360° without plastic deformation.
The material can be comprised of a single ply film or can comprise two or more layers which are either sealed together or separated to form a double wall container. Where the layers are sealed together, the film can comprise a laminated or extruded material. The laminated material comprises two or more separately formed layers that are subsequently secured together by an adhesive. The laminated and extruded films typically have between 1-9 layers and more commonly between 3-9 layers. The films used can commonly have a number of layers that is at least or less than 1, 3, 5, 7, or 9 layers or in a range between any two of the foreogiong. The extruded film can be a cast film such as a multi-layer co-extruded cast film.
Some extruded materials comprise a single integral sheet that comprises two or more layers of different materials that can be separated by a contact layer. All of the layers can be simultaneously co-extruded. One example of an extruded material that can be used in the present invention is the Thermo Scientific CX3-9 film available from Thermo Fisher Scientific. The Thermo Scientific CX3-9 film is a three-layer, 9 mil cast film produced in a cGMP facility. The outer layer is a polyester elastomer coextruded with an ultra-low density polyethylene product contact layer. Another example of an extruded material that can be used in the present invention is the Thermo Scientific CX5-14 cast film also available from Thermo Fisher Scientific. The Thermo Scientific CX5-14 cast film comprises a polyester elastomer outer layer, an ultra-low density polyethylene contact layer, and an ethylene vinyl alcohol (EVOH) barrier layer disposed therebetween. In still another example, a multi-web film produced from three independent webs of blown film can be used. The two inner webs are each a 4 mil monolayer polyethylene film while the outer barrier web is a 5.5 mil thick 6-layer co-extrusion film.
In some embodiments, the material can be approved (by a government or regulatory agency or other organization) for direct contact with living cells and/or capable of maintaining a solution sterile. In such an embodiment, the material can also be sterilizable such as by ionizing radiation. Examples of materials that can be used in different situations are disclosed in U.S. Pat. No. 6,083,587 which issued on Jul. 4, 2000 and United States Patent Publication No. US 2003-0077466 A1, published Apr. 24, 2003 which are hereby incorporated by specific reference.
In at least one embodiment, container 21, 21a comprises a two-dimensional, pillow style bag wherein two sheets of material are placed in overlapping relation and the two sheets are bounded together at their peripheries to form an (encircling) perimeter. The bounded sheets also form internal compartment 22 therebetween. Alternatively, a single sheet of material can be folded over and seamed around (at least some (e.g., the free edges) of) the periphery to form internal compartment 22. In another embodiment, the containers can be formed from a continuous tubular extrusion of polymeric material that is cut to length and is seamed closed at the (free or open) ends thereof.
In still other embodiments, container 21, 21a can comprise a three-dimensional bag that not only has an annular side wall but also a two dimensional top end wall and a two dimensional bottom end wall. Three dimensional containers comprise a plurality of discrete panels, typically three or more, and more commonly four or six. Each panel comprises a portion of an encircling side wall, top end wall, and bottom end wall of the container. Corresponding perimeter edges of each panel can be seamed together. The seams are typically formed using methods known in the art such as heat energies, radiofrequency (RF) energies, sonic energies or sonics, or other sealing energies. In alternative embodiments, the panels can be formed in a variety of different patterns.
It is appreciated that container 21, 21a can be manufactured to have virtually any desired size, shape, and configuration. For example, container 21, 21a can be formed having internal compartment 22 sized to at least, greater than, less than, between, or about 100 milliliters, 200 milliliters, 300 milliliters, 400 milliliters, 500 milliliters, 750 milliliters, 1 liter, 2 liters, or other desired volumes, including any volume or range of volumes therebetween. Although container 21, 21a can be or have any shape, in some embodiments, container 21, 21a is specifically configured to be complementary or substantially complementary (in size, shape, etc.) to the receiving area of a Dynamag™ CTS™ magnetic field generating device.
Although in the above discussed embodiment container 21, 21a has a flexible, bag configuration, in alternative embodiments it is appreciated that container 21, 21a can comprise any form of collapsible container or semi-rigid container. Container 21, 21a can also be opaque or non-opaque (transparent or translucent) and/or can have ultraviolet light inhibitors incorporated therein.
Container Inlets and Outlets
Returning now to
Openings 66 each have an exterior opening 67a disposed on outer perimeter edge 38, an interior opening 67b disposed on inner perimeter edge 37, and a passageway extending therebetween. Openings 66 also have a diameter (as discussed below). In at least one embodiment, the diameters of openings 66a and 66b can be or have similar measurements. For instance, the diameters can be substantially the same. Alternatively, one diameter can be greater than the other diameter. The diameter of openings 66 can have any suitable measurement. In certain embodiments, however, one or more of the diameters are sized to induce and/or ensure a specific flow rate of fluid therethrough (e.g., in response to a specific pump pressure or speed). For instance, in specific embodiments the diameters can be at least, up to, greater than, less than, between, or about 1 mm, 2 mm, 2.5 mm, 3 mm, 4 mm, 5 mm, 7.5 mm, 10 mm, 15 mm, 20 mm, and so forth, including any diameter or range of diameters therebetween.
In the depicted embodiment, inlet 24 and outlet 26 each comprise a tubular member 60 connected to opening 66. In particular, a first tubular member 60a extends at least partially through (or into) first opening 66a and a second tubular member 60b extends at least partially through (or into) second opening 66b. Tubular member 60 can be welded or otherwise connected to container 21 (e.g., seemed into opening 66) during the manufacturing of container 21). Alternatively, tubular member 60 can be coupled with opening 66 (such as by welding) after the manufacturing of container 21. Regardless of specific configuration, tubular member 60 can be connected to opening 66 so as to form a fluid (e.g., liquid) tight seal. Thus, tubular member(s) 60 can also be sterilizable (e.g., simultaneously with container 21) such as by ionizing radiation.
Although two tubular members 60 are shown, it is appreciated that container assembly 20 can include and/or be formed with any desired number of tubular members 60. For instance, in alternative embodiments, one or three or more tubular members 60 can be used. In at least one embodiment, a single, divided tubular member can be connected to an opening 66. The divided tubular member can have two passageways separated by a barrier. The two passageways can function as separate tubular members in certain embodiments.
Tubular member(s) 60 can also be connected at any desired location on container 21. As depicted, tubular members 60 extends into (e.g., at least partially through) joined perimeter 36 (or between upper sheet 32 and lower sheet 34) at first perimeter edge 50 (i.e., from exterior opening 67a to or toward interior opening 67b. In alternative embodiments, however, one or more tubular members 60 can extend through other perimeter edge(s), through upper container wall 32, and/or through lower container wall 34. Multiple tubular members 60 can be or have the same configurations or different configurations and can be used for a variety of different purposes.
As depicted in
Returning to
Tubular member 60 can also have any suitable length (i.e., between exterior opening 61a and interior opening 61b. As depicted in
As depicted in
With continued reference to
In certain embodiments, tubular member 60 can be integrally formed with fluid line 90 for (sterilely) delivering media, cell cultures, and/or other components into and out of container 21 or compartment 22 thereof. Thus, fluid line(s) 90 can also be sterilizable (e.g., simultaneously with container 21) such as by ionizing radiation.
Examples of tubular member 60 and how various fluid lines can be coupled to containers is disclosed in United States Patent Publication No. 2006-0270036, published Nov. 30, 2006 and United States Patent Publication No. 2006-0240546, published Oct. 26, 2006, which are incorporated herein by specific reference.
In the embodiment depicted in
Lengths L1 and L2 can be or have similar measurements. For instance, lengths L1 and L2 can be substantially the same. Alternatively, length L1 can be greater than length L2, or vice versa. In certain embodiments, length L1 and/or L2 can be greater than 1 mm, 2 mm, 3 mm, 4 mm, 5 mm, and so forth. For instance, length L1 and/or L2 can be between about 1 mm and about 10 cm, preferably between about 1 mm and about 5 cm, more preferably between about 1 mm and about 2.5 mm.
As further depicted in
Partitions
Returning now to
In at least one embodiment, partition 80 has a (sealed) first end 82 connected to and/or extending from a first location at (perimeter 36 or lower perimeter edge 50 thereof at) first side 51 of container 21. Partition 80 also has a second end 84 opposite first end 82 disposed at a second location within compartment 22. The first location is disposed between and proximal to inlet 24 and outlet 26 (or first opening 66a and second opening 66b thereof) and the second location is distal to inlet 24 and outlet 26 (or first opening 66a and second opening 66b thereof). Accordingly, partition 80 extends (from perimeter 36) beyond first opening 66a and second opening 66b a first distance or length L4 into internal compartment 22.
Illustrated in dashed lines are representations of various alternative lengths for partition 80. For instance, in an alternative embodiment, partition 80 can extend (from perimeter 36) beyond first opening 66a and second opening 66b a second distance or length L5, or a third distance or length L6, into internal compartment 22. As discussed in further detail below, in certain embodiments, distance or length L4, L5, L6 of partition 80 can be above a certain minimum threshold (e.g., in order to force a fluid into an inner or non-peripheral area of compartment 22). For instance, distance or length L4, L5, L6 can be at least, greater than, or about the same as diameter D1 of channel 64 (or opening 66), or (between) half of diameter D1, twice diameter D1, or 3, 4, 5, 10, 50, or 100 times diameter D1. Distance or length L4, L5, L6 can also, or alternatively, be up to, at least, greater than, or about one-twentieth the distance between inner perimeter edge 37 of lower perimeter edge 50 and inner perimeter edge 37 of upper perimeter edge 52, or one-tenth, one-fifth, one-fourth, one-third, one-half, or two-thirds the distance between inner perimeter edge 37 of lower perimeter edge 50 and inner perimeter edge 37 of upper perimeter edge 52.
As depicted, partition 80 does not extend (all the way) from inner perimeter edge 37 of lower perimeter edge 50 to inner perimeter edge 37 of upper perimeter edge 52 (or other portion(s) of perimeter 36). Accordingly, distance or length L4, L5, L6 of partition 80 can also be limited below a certain maximum threshold. For instance, distance or length L4, L5, L6 can up to, less than, between, or about 10 times, 50 times, 100 times, 150 times, 200 times, 250 times, 300 times or 350 times diameter D1 of channel 64 (or opening 66). Distance or length L4, L5, L6 can also, or alternatively, be up to, less than, between, or about one-fifth, one-fourth, one-third, one-half, two-thirds, three-fourths, or seven-eighths the distance between inner perimeter edge 37 of lower perimeter edge 50 and inner perimeter edge 37 of upper perimeter edge 52. In at least one embodiment, distance or length L4, L5, L6 can be (between) about 2.5 mm, 5 mm, 10 mm, 20 mm, 40 mm, 50 mm, 60 mm, 65 mm, 70 mm, 75 mm, 80 mm, 100 mm, 150 mm, 163 mm, 165 mm, 175 mm, or 200 mm, including any distance or length or range of distances or lengths therebetween.
As discussed in further detail below, the distance or length L4, L5, L6 that partition 80 extends into compartment 22 and/or away from opening 66, perimeter 36, lower perimeter edge 50, and/or inner perimeter edge 37 thereof can at least partially determined the efficacy (i.e., the ability or capacity to produce a desired effect or result), effectiveness (i.e., the degree of success in producing the desired effect or result), and/or efficiency (i.e., producing the desired effect or result with minimal waste, expense, or unnecessary effort) of container assembly 20 in operation and/or when implemented in a method of separating magnetic particles from a fluid.
As indicated above, in at least one embodiment, partition 80 can be formed by (permanently or reversibly) joining (i.e., securing) together upper and lower walls 32, 34 of container 21 (e.g., between the inlet 24 and the outlet 26). In certain embodiments, joining the upper and lower walls 32, 34 can include (substantially irreversibly) bonding the walls together, such as by welding, adhering, etc. (e.g., in substantially the same way that perimeter 36 is seamed together). In other embodiments, joining the upper and lower walls together can include (reversibly) joining walls 32, 34, such as by (externally) pressing, pinching, etc. walls 32, 34 together. In further embodiments, joining the upper and lower walls together can include disposing a dividing element, such as a (polymeric) barrier member, between and/or to walls 32, 34 and/or within the compartment. Regardless of the specific configuration, partition 80 can restrict (linear and/or substantially direct) fluid communication between inlet 24 and outlet 36. Accordingly, it will be appreciated that (fluid) material (e.g., liquid media, biological component, magnetic particles, etc.) disposed within compartment 22 cannot pass through partitions 80. Instead, as discussed in further detail below, a fluid disposed in compartment 22 (and/or flowing into container 21 through inlet 24) must pass (or flow) around (the second end 84 of) partition 80 in order to exit container 21 (or internal compartment 22 thereof) through outlet 26, as direct, linear access between fluid inlet 24 (or first opening 66a thereof) and fluid outlet 26 (or second opening 66b thereof) is restricted by partition 80.
As a result of partition 80, compartment 22 has or forms a fluid pathway 23 that extends from inlet 24 (or opening 66 thereof), around second end 84 of partition 80, to outlet 26 (or opening 66b thereto). The extended length of fluid pathway 23 can increase the retention or residence time of fluid within compartment 22 as compared to bag 10 that does not include a partition. As discussed in further detail below, this increased residence time induces and/or increases exposure of magnetic particles disposed in the fluid to a magnetic field 28 applied and/or generated (so as to be disposed or positioned) at least partially within compartment 22. As depicted in
Various additional partitions can be placed in a variety of different locations to form a variety of different flow paths. For instance,
It will further be appreciated that further modification of container assembly 20c can result in a substantially and/or inverse U-shaped container 21b. Those skilled in the art will appreciate, however, that the U-shaped configuration of lower perimeter edge 50a can comprise and/or form partition 80e regardless of its size, shape, etc. Accordingly, a fluid passing into internal compartment 22 through inlet 24 of container 21b must pass around partition 80e, through magnetic field 28a, in order to pass out of internal compartment 22 through outlet 26. As depicted in
Container assembly 20 can comprise and/or include any of the features described in relation to container assemblies disclosed herein. For instance, container assembly 20 includes container 21 having an internal compartment 22 and a partition 80 extending into compartment 22. Container assembly 20 also includes inlet tubular member 60a connected to fluid line 90a and outlet tubular member 60b connected to fluid line 90b, in fluid communication with compartment 22, and securing tabs 72a, 72b, and 72c.
Device 110 comprises an upper surface 114 and a receiving area 112. At least a portion of container assembly 20 and/or container 21 thereof is disposed on upper surface 114 and/or in receiving area 112. In one or more embodiments, receiving area 112 can be recessed into upper surface 114 of device 110. Accordingly, container 112 can be disposed and/or retained within the recess. Device 110 can also include one or more securing members 115 for receiving opening(s) 70 (e.g., to retain container 21 in a substantially constant and/or unchanged position or configuration on upper surface 114.
In at least one embodiment, device 110, upper surface 114, and/or receiving area 112 also comprises a recess (or (recessed) passage 113). Recess 113 can be positioned and/or configured to receive tubular member 60a and 60b therein (or allow tubular members 60 to pass therethrough without being structurally compromised. In particular, recess 113 can communicate with the recessed upper surface 114 and/or receiving area 112.
Device 110 also includes a magnetic field generating element 108 (
Device 110 also comprises a lid 116. Lid 116 can be (hingedly) connected to receiving area 112 in some embodiments. For instance, lid 116 can be connected to receiving area 112 with and/or by means of one or more hinge elements 118a, 118b. Lid 116 also includes a handle 124 actuating lid 116 into an opened configuration such that container 112 can be placed in receiving area 112 and/or on upper surface 114 thereof. Lid 116 can be retained in a closed configuration (as depicted in
In at least one embodiment, lid 116 can include a partition rib 119 (overlaying partition 80) extending from the inside surface of lid 116 (adjacent receiving area 112 or upper surface 114. In such embodiments, partition rib 119 can press together the opposing polymeric sheets of container 21 so as to form partition 80 within compartment 22. In particular, upper sheet 32 and lower sheet 34 can be secured (e.g., pinched or sandwiched) between (recessed) upper surface 114 and partition rib 119 such that a (substantially) fluid- or liquid-tight seal is formed between the opposing polymeric sheets (e.g., along the length of the partition rib 119). Accordingly, liquid within compartment 22 flows around partition 80 formed by the pinching of upper sheet 32 and lower sheet 34 between (recessed) upper surface 114 and partition rib 119.
Partition rib 119 can have a length as described above in relation to partition 80. Moreover, partition 80 can have a length corresponding to (at least a portion of) the length of partition rib 119. Partition rib 119 can also be positioned on the inner surface of lid 116 so as to avoid contacting, deforming, and/or interfering with the inlet 24, outlet 26, tubular members 60, and/or openings 66 thereof.
Assembly 100 also includes a base support 130. Device 110 can be hingedly connected to base support 130 by means of a hinge mechanism 132. Accordingly, device 110 can be disposed and/or maintained at an angle relative to base support 130 and/or a surface on which base 130 is placed. By way of illustration, handle 121 of device 110 can be actuated downward (e.g., toward base support 130 and/or a surface on which base 130 is placed) such that device 110 (and thereby container 21) is tilted downward.
Exemplary methods of separating magnetic particles from a fluid can be illustrated through the operation of assembly 100. It will be appreciated, however, that certain embodiments of the present disclosure can include methods that do not depend on and/or are not tied to one or more of the structural components of assembly 100. Accordingly, while a discussion of exemplary methods may be facilitated by reference to assembly 100, it is noted that components of assembly 100 as depicted in
Thus, by way of illustration only, one or more embodiments of the present disclosure can include introducing a fluid mixture into internal compartment 22 of a flexible container 21 through inlet 24, allowing at least a portion of the fluid mixture to travel around partition 80 and then exit internal compartment 22 through outlet 26, and applying magnetic field 28 to the fluid mixture in internal compartment 22. The fluid mixture can comprise a liquid media, a biological component, and magnetic particles in some embodiments. In some embodiments, the liquid media can comprise a cell culture media and the biological component can comprise cells (e.g., growing in the liquid media). For instance, in at least one embodiment, the fluid mixture comprises a suspension cell culture of cells (e.g., human T-cells disposed and growing in the liquid media. The magnetic particles can comprise inert and/or superparamagnetic beads having one or more antibodies (e.g., anti-CD3 and anti-CD28) coupled thereto. The beads can also have a substantially uniform diameter (e.g., about 4.5 μm) in some embodiments. In one or more embodiments, the beads (or antibodies thereof) can (immuno-) activate the cells for therapeutic functionality or purposes.
It will be appreciated that the method can also include disposing container assembly 20 (or container 21 thereof) on or in magnetic field-generating device 110, (recessed) upper surface 114, or (recessed) receiving area 112 thereof. In addition, openings 70 can be disposed on or about securing members 115, tubular members 60a, 60b can be disposed in passage 113, and/or lid 116 can be closed (e.g., against container 21 such that at least a portion of the container becomes flattened into a substantially two-dimensional configuration). Accordingly, container 21 can be (or become) sandwiched and/or otherwise disposed between (recessed) upper surface 114 (or receiving area 112) and closed lid 116. Lid 116 can also include a recessed portion 117 configured to accommodate (or avoid contact with) tubular members 60a, 60b in recess 113 (e.g., without deforming tubular members 60a, 60b so as to (substantially or entirely) restrict fluid flow therethrough).
Furthermore, fluid flowing into compartment 22 through inlet 24 (or inlet tubular member 60a thereof) may not (necessarily) fill compartment 22 so as to expand container 21 into a substantially three-dimensional configuration (e.g., because of the pillow style configuration of container 21 and/or the force of secured lid 116 against container 21).
In order to exit compartment 22, the fluid passes (or must pass) around partition 80 in order to reach outlet tubular member 60b. With container assembly 20 disposed on upper surface 114 or in receiving area 112, magnetic field 28 is also disposed and/or generated in compartment 22. Accordingly, a fluid flowing into compartment 22 through tubular member 60a, around partition 80, and out of compartment 22 through tubular member 60b, can pass (or must pass) through magnetic field 28.
In some embodiments, as indicated above, the length that partition 80 extends into compartment 22, etc. can at least partially determined the efficacy, effectiveness, and/or efficiency of container assembly 20 in operation and/or when implemented in a method of separating magnetic particles from a fluid (e.g., in assembly 100). In certain embodiments of the present disclosure, the length of partition 80 can be large enough and/or optimize to ensure that the magnetic particle-containing fluid can be exposed to magnetic field 28 to a degree sufficient to separate the magnetic particles from the fluid and/or other components disposed therein. For instance, in certain embodiments, the distance or length of partition 80 (e.g., from perimeter 36 and/or opening 66) is at least, greater than, or about the same as the diameter of opening 66, or (between) half of the diameter, twice the diameter, or 3, 4, 5, 10, 50, or 100 times the diameter of opening 66, including any length or range of lengths therebetween. The distance or length of partition 80 can also, or alternatively, be up to, at least, greater than, or about one-twentieth, one-tenth, one-fifth, one-fourth, one-third, one-half, or two-thirds the length of container 21 or compartment 22 thereof (e.g., between inner perimeter edge 37 of lower perimeter edge 50 and inner perimeter edge 37 of upper perimeter edge 52—see
Unlike existing systems that may require users to reduce the flow rate (e.g., below 30 mL/min, 20 mL/min, 15 mL/min, 10 mL/min, 5 mL/min, or 1 mL/min) in order to ensure a suitable exposure time to the magnetic field (see magnetic field 18 of
The fluid can also be introduced into compartment 22 at or above a fluid flow rate sufficient to permit the fluid to pass over and/or around partition 80. In at least one embodiment, the fluid can be introduced into container 21 or compartment 22 thereof (by means of fluid line 90a and inlet tubular member 60a) at of flow rate of at least, greater than, between, or about 10 mL/min, 20 mL/min, 30 mL/min, 50 mL/min, 100 mL/min, 150 mL/min, 200 mL/min, 250 mL/min, 300 mL/min, 350 mL/min, 400 mL/min, and so forth, including any flow rate or range of flow rates therebetween.
In addition, the fluid can be introduced into compartment 22 at (or below) a fluid flow rate (e.g., sufficient to permit the fluid to be exposed to magnetic field 28 for a suitable period of time). Specifically, in order to increase and/or sustain exposure of the fluid to magnetic field 28, the fluid flow rate may need to be maintained under a certain level. In at least one embodiment, the fluid can be introduced into container 21 or compartment 22 thereof (by means of fluid line 90a and inlet tubular member 60a) at of flow rate of up to, less than, between, or about 35 mL/min, 40 mL/min, 50 mL/min, 100 mL/min, 150 mL/min, 200 mL/min, 250 mL/min, 300 mL/min, 350 mL/min, 400 mL/min, 500 mL/min, 750 mL/min, 1 L/min, and so forth, including any flow rate or range of flow rates therebetween.
The magnetic particles can (thereby) be (or become) retained within container 21 and/or compartment 22 thereof by magnetic field 28 as the media and biological component flow from inlet 24, around partition 80, and to outlet 26. Accordingly, the portion of the mixture that exits internal compartment 22 can be substantially devoid of magnetic particles. For instance, the portion of the fluid mixture that exits internal compartment 22 through outlet 24 can have less than 5000, 4000, 3000, or 2000, preferably less than 1000, 750, 500, or 250, more preferably less than 200, 150, 100, or 50, most preferably less than 40, 30, 25, 20, 15, or 10 magnetic particles per milliliter of liquid media. Thus, in addition to the time savings produced by increasing the flow rate of fluid sample through compartment 22, embodiments of the present disclosure can retain more beads and/or a higher percentage of beads than certain existing containers.
The concentration of the biological component in the portion of the mixture that exits the internal compartment, however, can be substantially the same as the concentration of the biological component in the introduced fluid mixture in some embodiments. For instance, the concentration of the biological component in the portion of the mixture that exits the internal compartment can be at least, greater than, between, or about 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% of the concentration of the biological component in the introduced fluid mixture. In other embodiments, the concentration of the biological component in the portion of the mixture that exits the internal compartment can be at least, greater than, between, or about 10%, 25%, 50%, 60%, 70%, or 75%, of the concentration of the biological component in the introduced fluid mixture. For instance, certain embodiments may involve flowing the sample through the system at a high flow rate, and recirculating the recovered product through the container.
With upper surface 114 oriented in certain non-perpendicular angles relative to the force of gravity (e.g., by means of hinge mechanism 132), the fluid can drain from compartment 22 through tubular member 60b under the (at least partial) assistance of gravity. However, in such an orientation, fluid flowing into compartment 22 through tubular member 60a must overcome the (at least partial) force of gravity in order to eclipse and/or pass over (i.e., flow around) partition 80. Failure of the fluid to eclipse and/or pass over (i.e., flow around) partition 80 (and/or reach outlet 26) can result in loss of the biological component (disposed in the liquid media).
In some embodiments, the biological component (e.g., human T-cells or other therapeutic component) can be fragile. Thus, squeezing or rolling container 21, or implementing a container scrapper to move the fluid over partition 80 and to outlet 26 can damage (e.g., rupture) the biological component. Such damage can reduce the potency and/or usability of the biological component. Moreover, the additional expense of man-hours required to manually harvest the biological component can add to the baseline cost of producing (e.g., growing, expanding, activating, etc.) and purifying the biological component can destroy and/or negate the commercial viability to large-scale purification of the biological component. Accordingly, efficacious, effective, and/or efficient separation of magnetic particles may only be one of a plurality of concerns in performing the steps of a method of separating magnetic particles from a fluid (e.g., in assembly 100).
Without being bound to any theory, the longer and/or further partition 80 extends into compartment 22, the longer magnetic beads can be exposed to magnetic field 28. However, longer partitions can trap biological component-containing liquid in the container, reducing recover of the biological component. Accordingly, in certain embodiments, the length of partition 80 can be optimized (e.g., above a certain minimum threshold and below a certain maximum threshold) in order to maximize and/or optimize the amount of fluid that reaches tubular member 60b and/or exits compartment 22 through outlet 26. For instance, in order to maximize product recovery and/or minimize additional recovery efforts, the size of partition 80 can be reduced below a certain length. In some embodiments, the length of partition 80 can be up to, less than, between, or about 10 times, 50 times, 100 times, 150 times, 200 times, 250 times, 300 times or 350 times diameter of opening 66, including any length or range of lengths therebetween.
In certain embodiments, the length of partition 80 can also, or alternatively, be up to, less than, between, or about one-fifth, one-fourth, one-third, one-half, two-thirds, three-fourths, or seven-eighths the length of container 21 or compartment 22 thereof (e.g., between inner perimeter edge 37 of lower perimeter edge 50 and inner perimeter edge 37 of upper perimeter edge 52—see
The shape of container 21 and/or compartment 22 thereof can also affect the ability or tendency of fluid to flow from inlet 24, around partition 80, and to outlet 26. Where device 110 (and thereby container 21) is tilted downward, as described above, the fluid introduced into compartment 22 through opening 66 can tend to settle downward (e.g., back towards inlet 24) under the force of gravity. In some embodiments, partition 80 can form (an undesirable) pocket(s) with perimeter 36 (e.g., in the lower portion of compartment 22). Just as the lower corners of container 21 or compartment 22 thereof can form a fluid retention pockets (e.g., eliminated by transition perimeter edges 58), the side and/or upper portions (e.g., upper corners) of container 21 or compartment 22 thereof can also retain fluid therein.
With reference to
System 200 can also include a pump 230 in fluid communication with container 212 via a first fluid line 215. Pump 230 can draw a fluid mixture 220 out of container 212 and, by means of a second fluid line 225, and pump fluid mixture 220 to assembly 100 (see
Pump 230 can also draw fluid from container assembly 20 (or container 21 thereof) through a third fluid line 235. In at least one embodiment, third fluid line 235 can comprise or be coupled with fluid line 90b depicted in
In certain embodiments, pump 230 can re-cycle the fluid product through assembly 100 by means of second fluid line 225 and third fluid line 235. In other embodiments, however, the fluid product need not be re-cycled. Instead, the fluid product can be pumped into a collection container 250 via a fourth fluid line 245. Collection container 250 can also comprise a flexible, sterilizable bag in some embodiments.
Accordingly, with reference to the
Embodiments can also include removing a second fluid mixture 240 from the compartment 22 through a second opening 66b disposed in the first side 50 of the container 21 adjacent to the first opening 66a, the second mixture 240 comprising the liquid media and the biological component disposed in the liquid media at a second concentration, the second concentration being greater than 90% of the first concentration, the magnetic field 28 retaining at least a portion of the first amount of magnetic particles in the compartment 22, the compartment 22 having a partition 80 formed therein, the partition 80 comprising a joinder of the upper container wall 32 and lower container wall 34, the partition 80 having a sealed first end 82 extending from the first side 50 of the container 21 between the first opening 66a and the second opening 66b, and a second end 84 opposite the first end 82 disposed at a second location within the compartment 22 such that the liquid media and the biological component must pass from the first opening 66a, around the partition 80, and to the second opening 66b in order to be removed from the compartment 22, the second fluid 240 comprising less than 5000 magnetic particles per milliliter of liquid media.
Various alterations and/or modifications of the inventive features illustrated herein, and additional applications of the principles illustrated herein, which would occur to one skilled in the relevant art and having possession of this disclosure, can be made to the illustrated embodiments without departing from the spirit and scope of the invention as defined by the claims, and are to be considered within the scope of this disclosure. Thus, while various aspects and embodiments have been disclosed herein, other aspects and embodiments are contemplated. While a number of methods and components similar or equivalent to those described herein can be used to practice embodiments of the present disclosure, only certain components and methods are described herein.
It will also be appreciated that systems, processes, and/or products according to certain embodiments of the present disclosure may include, incorporate, or otherwise comprise properties, features (e.g., components, members, elements, parts, and/or portions) described in other embodiments disclosed and/or described herein. Accordingly, the various features of certain embodiments can be compatible with, combined with, included in, and/or incorporated into other embodiments of the present disclosure. Thus, disclosure of certain features relative to a specific embodiment of the present disclosure should not be construed as limiting application or inclusion of said features to the specific embodiment. Rather, it will be appreciated that other embodiments can also include said features without necessarily departing from the scope of the present disclosure. Moreover, unless a feature is described as requiring another feature in combination therewith, any feature herein may be combined with any other feature of a same or different embodiment disclosed herein. Furthermore, various well-known aspects of illustrative systems, processes, products, and the like are not described herein in particular detail in order to avoid obscuring aspects of the example embodiments. Such aspects are, however, also contemplated herein.
The present disclosure may be embodied in other specific forms without departing from its spirit or essential characteristics. The described embodiments are to be considered in all respects only as illustrative and not restrictive. The scope of the invention is, therefore, indicated by the appended claims rather than by the foregoing description. While certain embodiments and details have been included herein and in the attached disclosure for purposes of illustrating embodiments of the present disclosure, it will be apparent to those skilled in the art that various changes in the methods, products, devices, and apparatus disclosed herein may be made without departing from the scope of the disclosure or of the invention, which is defined in the appended claims. All changes which come within the meaning and range of equivalency of the claims are to be embraced within their scope.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2016/068067 | 12/21/2016 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2017/116910 | 7/6/2017 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
3140716 | Harrison et al. | Jul 1964 | A |
3212274 | Eidus | Oct 1965 | A |
3221724 | Wentworth | Dec 1965 | A |
3304977 | Hammons | Feb 1967 | A |
3422887 | Berkeley | Jan 1969 | A |
3672959 | Sweet | Jun 1972 | A |
3690045 | Neumann | Sep 1972 | A |
3867260 | Freedman | Feb 1975 | A |
4112829 | Poinsard | Sep 1978 | A |
4177816 | Torgeson | Dec 1979 | A |
4182656 | Ahnell et al. | Jan 1980 | A |
4194950 | Zalles | Mar 1980 | A |
4197098 | Stiehl | Apr 1980 | A |
4258784 | Perry et al. | Mar 1981 | A |
4309592 | Le Boeuf | Jan 1982 | A |
4561498 | Nowobilski et al. | Dec 1985 | A |
4573933 | Camron | Mar 1986 | A |
4574876 | Aid | Mar 1986 | A |
4612086 | Dominguez | Sep 1986 | A |
4668388 | Dibble et al. | May 1987 | A |
4731072 | Aid | Mar 1988 | A |
4744414 | Schon | May 1988 | A |
4797587 | Tschudi et al. | Jan 1989 | A |
4863452 | Irmiter et al. | Sep 1989 | A |
4910148 | Sorensen et al. | Mar 1990 | A |
4935134 | Hensgen | Jun 1990 | A |
5121857 | Hutchinson | Jun 1992 | A |
5243833 | Coelho et al. | Sep 1993 | A |
5245693 | Ford et al. | Sep 1993 | A |
5271557 | Lynch et al. | Dec 1993 | A |
5287918 | Banks et al. | Feb 1994 | A |
5306269 | Lewis et al. | Apr 1994 | A |
5350513 | Markowitz | Sep 1994 | A |
5372621 | Staton | Dec 1994 | A |
5381510 | Ford et al. | Jan 1995 | A |
5411077 | Tousignant | May 1995 | A |
5417729 | Greenleaf, Sr. | May 1995 | A |
5443985 | Lu et al. | Aug 1995 | A |
5512141 | Koistinen et al. | Apr 1996 | A |
5536475 | Moubayed et al. | Jul 1996 | A |
5632793 | Haggard | May 1997 | A |
5691208 | Miltenyi | Nov 1997 | A |
5875282 | Jordan et al. | Feb 1999 | A |
5885453 | Chatelin et al. | Mar 1999 | A |
6003593 | Halligan | Dec 1999 | A |
6083587 | Smith et al. | Jul 2000 | A |
6126835 | Barbera-Guillem et al. | Oct 2000 | A |
6133021 | Gu et al. | Oct 2000 | A |
6165105 | Boutellier et al. | Dec 2000 | A |
6391093 | French | May 2002 | B1 |
6409785 | Smithies et al. | Jun 2002 | B1 |
6432698 | Gaugler et al. | Aug 2002 | B1 |
6490824 | Maekawa et al. | Dec 2002 | B1 |
6535689 | Augustine et al. | Mar 2003 | B2 |
6619054 | Cargnelli et al. | Sep 2003 | B1 |
6626983 | Cairns | Sep 2003 | B1 |
6673098 | Machold et al. | Jan 2004 | B1 |
6673598 | Akers et al. | Jan 2004 | B1 |
6882797 | Stewart et al. | Apr 2005 | B2 |
7004196 | Schubmehl et al. | Feb 2006 | B2 |
7011797 | Bakke | Mar 2006 | B2 |
7232457 | Schmidt et al. | Jun 2007 | B2 |
7235402 | Aubry | Jun 2007 | B2 |
7289724 | Furnrohr et al. | Oct 2007 | B2 |
7384783 | Kunas et al. | Jun 2008 | B2 |
7394976 | Entenman et al. | Jul 2008 | B2 |
7487688 | Goodwin | Feb 2009 | B2 |
7629167 | Hodge et al. | Dec 2009 | B2 |
7682067 | West et al. | Mar 2010 | B2 |
7722839 | Kuzyk | May 2010 | B2 |
7748438 | Ghelli et al. | Jul 2010 | B2 |
7819934 | Galliher | Oct 2010 | B2 |
7831318 | Bartee et al. | Nov 2010 | B2 |
7878099 | Loibl | Feb 2011 | B2 |
7879599 | Goodwin et al. | Feb 2011 | B2 |
7932078 | Posseme et al. | Apr 2011 | B2 |
8381780 | Fisher et al. | Feb 2013 | B2 |
8455242 | Staheli et al. | Jun 2013 | B2 |
8506198 | West et al. | Aug 2013 | B2 |
8603805 | Goodwin et al. | Dec 2013 | B2 |
8623640 | Kunas et al. | Jan 2014 | B2 |
8641314 | Thacker et al. | Feb 2014 | B2 |
9457306 | Jones et al. | Oct 2016 | B2 |
20010024820 | Mastromatteo et al. | Sep 2001 | A1 |
20010039692 | Wright et al. | Nov 2001 | A1 |
20020131654 | Smith et al. | Sep 2002 | A1 |
20030077466 | Smith et al. | Apr 2003 | A1 |
20030106294 | Chung et al. | Jun 2003 | A1 |
20040062140 | Cadogan et al. | Apr 2004 | A1 |
20040149127 | Lyons | Aug 2004 | A1 |
20040209331 | Ririe | Oct 2004 | A1 |
20050239198 | Kunas et al. | Oct 2005 | A1 |
20050272146 | Hodge et al. | Dec 2005 | A1 |
20050287660 | Aubry | Dec 2005 | A1 |
20060196501 | Bibbo et al. | Sep 2006 | A1 |
20060240546 | Goodwin et al. | Oct 2006 | A1 |
20060270036 | Goodwin et al. | Nov 2006 | A1 |
20060275894 | Felder et al. | Dec 2006 | A1 |
20060279167 | Turner | Dec 2006 | A1 |
20070175831 | Almaasbak et al. | Aug 2007 | A1 |
20070199890 | Trogolo | Aug 2007 | A1 |
20070275452 | Yamasaki et al. | Nov 2007 | A1 |
20080060216 | Reilly | Mar 2008 | A1 |
20080068920 | Galliher et al. | Mar 2008 | A1 |
20080127832 | Zhang | Jun 2008 | A1 |
20080160591 | Willson et al. | Jul 2008 | A1 |
20080272146 | Hodge et al. | Dec 2008 | A1 |
20090035856 | Galliher et al. | Feb 2009 | A1 |
20090081742 | Dunlop et al. | Mar 2009 | A1 |
20090087903 | Belgrader et al. | Apr 2009 | A1 |
20090119869 | Yoo | May 2009 | A1 |
20090148143 | Entenman et al. | Jun 2009 | A9 |
20090233334 | Hildinger et al. | Sep 2009 | A1 |
20100075405 | Broadley et al. | Mar 2010 | A1 |
20100124564 | Martinson et al. | May 2010 | A1 |
20100151558 | Alianell et al. | Jun 2010 | A1 |
20100170400 | van den Boogard et al. | Jul 2010 | A1 |
20100229296 | Samuel | Sep 2010 | A1 |
20100237009 | Horst | Sep 2010 | A1 |
20100248333 | Bartilson | Sep 2010 | A1 |
20110046551 | Augustine et al. | Feb 2011 | A1 |
20110076759 | Reif et al. | Mar 2011 | A1 |
20110124087 | Meiser et al. | May 2011 | A1 |
20110188928 | West et al. | Aug 2011 | A1 |
20110198066 | Starbard | Aug 2011 | A1 |
20110198286 | Niazi | Aug 2011 | A1 |
20110207170 | Niazi | Aug 2011 | A1 |
20110207218 | Staheli et al. | Aug 2011 | A1 |
20110258975 | Lundgren | Oct 2011 | A1 |
20110310696 | Goodwin et al. | Dec 2011 | A1 |
20120094785 | Cheng et al. | Apr 2012 | A1 |
20120132548 | Galliher et al. | May 2012 | A1 |
20120177533 | Lee et al. | Jul 2012 | A1 |
20120260671 | Damren et al. | Oct 2012 | A1 |
20130082410 | Goodwin et al. | Apr 2013 | A1 |
20130089925 | Damren et al. | Apr 2013 | A1 |
20130101982 | Goodwin et al. | Apr 2013 | A1 |
20130260463 | Staheli et al. | Oct 2013 | A1 |
20140106453 | Kunas et al. | Apr 2014 | A1 |
20140251322 | Miller | Sep 2014 | A1 |
20140298612 | Williams et al. | Oct 2014 | A1 |
20150265943 | Brown et al. | Sep 2015 | A1 |
20150265958 | Brown et al. | Sep 2015 | A1 |
20180291364 | Liberti | Oct 2018 | A1 |
Number | Date | Country |
---|---|---|
2642387 | Sep 2004 | CN |
1649654 | Aug 2005 | CN |
201396935 | Feb 2010 | CN |
20 2009 006 839 | Aug 2009 | DE |
10 2008 027 638 | Dec 2009 | DE |
0 073 079 | Mar 1986 | EP |
0 400 829 | Dec 1990 | EP |
0 471 947 | Jun 1991 | EP |
1 837 640 | Sep 2007 | EP |
1 950 281 | Jul 2008 | EP |
2 065 085 | Jun 2009 | EP |
2 123 745 | Nov 2009 | EP |
2886645 | Jun 2015 | EP |
2491623 | Dec 2012 | GB |
58-47485 | Mar 1983 | JP |
61-149080 | Jul 1986 | JP |
3-196836 | Aug 1991 | JP |
H04-118015 | Apr 1992 | JP |
H04-122618 | Nov 1992 | JP |
05-168463 | Jul 1993 | JP |
08-70845 | Mar 1996 | JP |
8-501927 | Mar 1996 | JP |
9-14837 | Jan 1997 | JP |
H10-505542 | Jun 1998 | JP |
H10-216446 | Aug 1998 | JP |
11-512968 | Nov 1999 | JP |
H11-333239 | Dec 1999 | JP |
2002-3505 | Jan 2002 | JP |
2004-271031 | Sep 2004 | JP |
2007-534335 | Nov 2007 | JP |
2009-50838 | Mar 2009 | JP |
2009-539408 | Nov 2009 | JP |
2009-291192 | Dec 2009 | JP |
2012-170364 | Sep 2012 | JP |
101152862 | Jun 2012 | KR |
9401530 | Jan 1994 | WO |
2003092849 | Nov 2003 | WO |
2006116139 | Nov 2006 | WO |
2009093995 | Jul 2009 | WO |
2009146769 | Dec 2009 | WO |
2011041508 | Apr 2011 | WO |
2011078773 | Jun 2011 | WO |
2011110726 | Sep 2011 | WO |
2012170878 | Dec 2012 | WO |
2013009668 | Jan 2013 | WO |
2013032392 | Mar 2013 | WO |
2013053779 | Apr 2013 | WO |
2016164635 | Oct 2016 | WO |
Entry |
---|
International Search Report and Written Opinion dated Apr. 3, 2017, issued in PCT Application No. PCT/US2016/068067, filed Dec. 21, 2016. |
G. Catapano et al., Bioreactor Design and Scale Up, Chapter 5 of Cell and Tissue Reaction Engineering, 2009, pp. 173-259. |
Minghui Hu et al., Study of an Efficient Temperature Measurement for an Industrial Bioreactor, ScienceDirect, Measure, vol. 44, 2011, pp. 875-880. |
Zhiwei Zhou et al., Optimizing of Bioreactor Heat Supply and Material Feeding by Numberical Calculation, ICICIS, 2011, pp. 195-202. |
Discovery Scientific Product Lines, Discovery Scientific, http://discoveryscientific.com/products-by-type2/b/mammalian-insect-cell-culture-bioreactor, Apr. 25, 2014, 3 pages. |
DASbox Single-Use Vessel, Brochure, DASGIP Information and Process Technology, GMBH, 2012, 2 pages. |
Number | Date | Country | |
---|---|---|---|
20190010435 A1 | Jan 2019 | US |
Number | Date | Country | |
---|---|---|---|
62272585 | Dec 2015 | US |